Syndax Pharmaceuticals Inc (SNDX)
21.85
-0.09
(-0.41%)
USD |
NASDAQ |
May 02, 16:00
21.85
0.00 (0.00%)
After-Hours: 19:29
Syndax Pharmaceuticals Max Drawdown (5Y): 68.30% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 68.30% |
| March 31, 2024 | 68.30% |
| February 29, 2024 | 68.30% |
| January 31, 2024 | 68.30% |
| December 31, 2023 | 73.15% |
| November 30, 2023 | 73.15% |
| October 31, 2023 | 75.13% |
| September 30, 2023 | 78.98% |
| August 31, 2023 | 78.98% |
| July 31, 2023 | 78.98% |
| June 30, 2023 | 78.98% |
| May 31, 2023 | 78.98% |
| April 30, 2023 | 78.98% |
| March 31, 2023 | 78.98% |
| February 28, 2023 | 78.98% |
| January 31, 2023 | 78.98% |
| December 31, 2022 | 78.98% |
| November 30, 2022 | 78.98% |
| October 31, 2022 | 78.98% |
| September 30, 2022 | 78.98% |
| August 31, 2022 | 78.98% |
| July 31, 2022 | 78.98% |
| June 30, 2022 | 78.98% |
| May 31, 2022 | 78.98% |
| April 30, 2022 | 78.98% |
| Date | Value |
|---|---|
| March 31, 2022 | 78.98% |
| February 28, 2022 | 78.98% |
| January 31, 2022 | 78.98% |
| December 31, 2021 | 78.98% |
| November 30, 2021 | 78.98% |
| October 31, 2021 | 78.98% |
| September 30, 2021 | 78.98% |
| August 31, 2021 | 78.98% |
| July 31, 2021 | 78.98% |
| June 30, 2021 | 78.98% |
| May 31, 2021 | 78.98% |
| April 30, 2021 | 78.98% |
| March 31, 2021 | 78.98% |
| February 28, 2021 | 78.98% |
| January 31, 2021 | 78.98% |
| December 31, 2020 | 78.98% |
| November 30, 2020 | 78.98% |
| October 31, 2020 | 78.98% |
| September 30, 2020 | 78.98% |
| August 31, 2020 | 78.98% |
| July 31, 2020 | 78.98% |
| June 30, 2020 | 78.98% |
| May 31, 2020 | 78.98% |
| April 30, 2020 | 78.98% |
| March 31, 2020 | 78.98% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
68.30%
Minimum
Jan 2024
78.98%
Maximum
May 2019
78.01%
Average
78.98%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| SpringWorks Therapeutics Inc | -- |
| Alnylam Pharmaceuticals Inc | 52.27% |
| Geron Corp | 86.09% |
| Ionis Pharmaceuticals Inc | 70.27% |
| Madrigal Pharmaceuticals Inc | 82.20% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 10.90 |
| Beta (5Y) | 1.009 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 65.40% |
| Historical Sharpe Ratio (5Y) | 0.3387 |
| Historical Sortino (5Y) | 0.7346 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.27% |